Could pressure to make money faster kill the next lifesaving pill?

• / Activist investors pressuring pharmaceutical companies to prioritize short-term profits.
• / Shift in drug-development strategies may result in fewer lifesaving medications being developed.
• / Patients may suffer when companies focus more on financial returns than medical innovation.

AI-generated summary for informational purposes. Verify with original source.